OTC Reform Impact May Be Exaggerated
The impact of reform of the over-the-counter markets on fixed-income revenue may have been overestimated, according to a report by Morgan Stanley and Oliver Wyman.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
